Assessing the nutritional quality of Pleurotus ostreatus (oyster mushroom) DOI Creative Commons
Magdalene Eno Effiong,

Chidinma Precious Umeokwochi,

Israel Sunmola Afolabi

et al.

Frontiers in Nutrition, Journal Year: 2024, Volume and Issue: 10

Published: Jan. 16, 2024

There is a huge gap between food production and the exploding population demands in various parts of world, especially developing countries. This increases chances malnutrition, leading to increased disease incidence need for functional foods reduce mortality. Pleurotus ostreatus are edible mushrooms that cheaply sourced rich nutrient with potential be harnessed toward addressing present future crisis while serving as prevention treatment. study evaluated nutritional, proximate, vitamins amino acids contents . The proximate composition this revealed it contains 43.42% carbohydrate, 23.63% crude fiber, 17.06% protein, 8.22% ash, 1.21% lipid moisture content 91.01 6.46% fresh dry samples ostreatus, respectively monosaccharide disaccharide profile presence glucose (55.08 g/100 g), xylose (7.19 fructose (19.70 galactose (17.47 trehalose (7.37 chitobiose (11.79 maltose (29.21 sucrose (51.60 g) lower amounts cellobiose (0.01 erythrose (0.48 other unidentified sugars. Potassium, Iron Magnesium were highest minerals 12.25 mg, 9.66 mg 7.00 amounts, respectively. vitamin A (2.93 IU/100 C (16.46 mg/100 E (21.50 B B2 having concentration 92.97 mg/kg. acid scores showed had more non-essential (564.17 than essential (67.83 ratio 0.11. Lysine (23.18 was aspartic (492.12 mg/kg) It higher acidic acids, 492.12 g (77.87%), followed by neutral 106.66 (16.88%) least basic 23.18 (3.67%). Based on nutritional assessment analyzed study, can concluded serve an important source exploited meet increasing micronutrient deficiencies many

Language: Английский

The Intestinal Microbiota and Colorectal Cancer DOI Creative Commons
Yiwen Cheng, Zongxin Ling, Lanjuan Li

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: Nov. 30, 2020

The intestinal microbiota, composed of a large population microorganisms, is often considered "forgotten organ" in human health and diseases. Increasing evidence indicates that dysbiosis the microbiota closely related to colorectal cancer (CRC). roles for microorganisms initiated facilitated CRC process are becoming increasingly clear. Hypothesis models have been proposed illustrate complex relationship between CRC. Recent studies identified Streptococcus bovis, enterotoxigenic Bacteroides fragilis, Fusobacterium nucleatum, Enterococcus faecalis, Escherichia coli, Peptostreptococcus anaerobius as candidate pathogens. In this review, we summarized mechanisms involved microbiota-related carcinogenesis, including inflammation, pathogenic bacteria, their virulence factors, genotoxins, oxidative stress, bacterial metabolites, biofilm. We also described clinical values novel strategies preventing treating

Language: Английский

Citations

400

High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites DOI
Jia Yang, Hong Wei, Yunfei Zhou

et al.

Gastroenterology, Journal Year: 2021, Volume and Issue: 162(1), P. 135 - 149.e2

Published: Aug. 27, 2021

Language: Английский

Citations

325

Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies DOI Creative Commons

Frederik Soetaert,

Preethi Korangath, David Serantes

et al.

Advanced Drug Delivery Reviews, Journal Year: 2020, Volume and Issue: 163-164, P. 65 - 83

Published: Jan. 1, 2020

Significant research and preclinical investment in cancer nanomedicine has produced several products, which have improved care. Nevertheless, there exists a perception that 'has not lived up to its promise' because the number of approved products their clinical performance are modest. Many these analyses do consider long history many developed from iron oxide nanoparticles. Iron nanoparticles enjoyed use for about nine decades demonstrating safety, considerable utility versatility. FDA-approved applications include diagnosis, hyperthermia therapy, deficiency anemia. For nanomedicine, this wealth experience is invaluable provide key lessons highlight pitfalls pursuit nanotechnology-based therapeutics. We review with systemic liposomal drug delivery parenteral therapy anemia (IDA) note success injectable exploits inherent interaction between (innate) immune system, designers seek avoid. Magnetic fluid hyperthermia, harnesses magnetic hysteresis heating treating humans only Despite successful demonstration enhance overall survival trials, thermal medicine struggles establish presence. physical biological attributes approach, suggest reasons barriers acceptance. Finally, despite extensive new exciting points surprising immune-modulating potential. Recent data demonstrate interactions cells can induce anti-tumor responses. These present opportunities explore additional venerable technology. Clinical poignant case studies opportunities, complexities, challenges nanomedicine. They also illustrate need revised paradigms multidisciplinary approaches develop translate nanomedicines into

Language: Английский

Citations

322

Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon DOI
Cuiling Guo, Dandan Guo, Liu Fang

et al.

Carbohydrate Polymers, Journal Year: 2021, Volume and Issue: 267, P. 118231 - 118231

Published: May 20, 2021

Language: Английский

Citations

288

Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America DOI
Na Li, Bin Lu, Chenyu Luo

et al.

Cancer Letters, Journal Year: 2021, Volume and Issue: 522, P. 255 - 268

Published: Sept. 24, 2021

Language: Английский

Citations

275

Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study DOI Creative Commons

Yiwen Long,

Lanhua Tang,

Yangying Zhou

et al.

BMC Medicine, Journal Year: 2023, Volume and Issue: 21(1)

Published: Feb. 21, 2023

Abstract Background Evidence from observational studies and clinical trials suggests that the gut microbiota is associated with cancer. However, causal association between cancer remains to be determined. Methods We first identified two sets of based on phylum, class, order, family, genus level information, data were obtained IEU Open GWAS project. then performed two-sample Mendelian randomisation (MR) determine whether causally eight types. Furthermore, we a bi-directional MR analysis examine direction relations. Results 11 relationships genetic liability in microbiome cancer, including those involving Bifidobacterium . found 17 strong associations Moreover, 24 using multiple datasets. Conclusions Our revealed was cancers may useful providing new insights for further mechanistic microbiota-mediated

Language: Английский

Citations

256

Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance DOI Creative Commons
Hannah N. Bell, Ryan Rebernick, Joshua Goyert

et al.

Cancer Cell, Journal Year: 2021, Volume and Issue: 40(2), P. 185 - 200.e6

Published: Dec. 23, 2021

Language: Английский

Citations

186

Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer DOI
Ni Wang, Jing‐Yuan Fang

Trends in Microbiology, Journal Year: 2022, Volume and Issue: 31(2), P. 159 - 172

Published: Sept. 1, 2022

Language: Английский

Citations

177

Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy DOI
Zhaoting Li, Yixin Wang, Jun Liu

et al.

Advanced Materials, Journal Year: 2021, Volume and Issue: 33(38)

Published: Aug. 4, 2021

Abstract Bacteria are one of the main groups organisms, which dynamically and closely participate in human health disease development. With integration chemical biotechnology, bacteria have been utilized as an emerging delivery system for various biomedical applications. Given unique features such their intrinsic biocompatibility motility, bacteria‐based systems drawn wide interest diagnosis treatment diseases, including cancer, infectious kidney failure, hyperammonemia. Notably, at interface biotechnology bacteria, many research opportunities initiated, opening a promising frontier application. Herein, current synergy design principles systems, microbial modulation, clinical translation reviewed, with special focus on advances therapy.

Language: Английский

Citations

175

Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? DOI

Huiqin Hou,

Danfeng Chen, Kexin Zhang

et al.

Cancer Letters, Journal Year: 2021, Volume and Issue: 526, P. 225 - 235

Published: Nov. 26, 2021

Language: Английский

Citations

153